Hosted on MSN
Investing in graphene companies
UK-based global chemicals manufacturer Thomas Swan & Co. holds a 15 percent interest in Black Swan and brings a portfolio of patents and intellectual property related to graphene production. Through ...
Management reiterated fiscal year 2025 revenue guidance of $140 million to $155 million but signaled expectations to be at the lower end of the range due to macroeconomic uncertainties, including ...
Graphene has the potential to spur advances in a variety of sectors, from transport to medicine to electronics. Unfortunately, the high cost of graphene production has slowed commercialization.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results